142 related articles for article (PubMed ID: 37218572)
1. Male Accessory Breast Cancer Successfully Treated With Single-Agent Trastuzumab: A Case Report.
Ji W; Guo W
Am J Mens Health; 2023; 17(3):15579883231171010. PubMed ID: 37218572
[TBL] [Abstract][Full Text] [Related]
2. [A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Jinno H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2396-8. PubMed ID: 24394124
[TBL] [Abstract][Full Text] [Related]
3. A male with primary accessory breast carcinoma in an axilla is strongly suspected of having hereditary breast cancer.
Takahashi E; Terata K; Nanjo H; Ishiyama K; Hiroshima Y; Yamaguchi A; Yatsuyanagi M; Kudo C; Wakita A; Takashima S; Sato Y; Imai K; Motoyama S; Minamiya Y
Int Cancer Conf J; 2021 Apr; 10(2):107-111. PubMed ID: 33782642
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis.
Leung W; Kvizhinadze G; Nair N; Blakely T
PLoS Med; 2016 Aug; 13(8):e1002067. PubMed ID: 27504960
[TBL] [Abstract][Full Text] [Related]
5. Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist.
Gahlaut R; Bennett A; Fatayer H; Dall BJ; Sharma N; Velikova G; Perren T; Dodwell D; Lansdown M; Shaaban AM
Eur J Cancer; 2016 Jun; 60():40-8. PubMed ID: 27062316
[TBL] [Abstract][Full Text] [Related]
6. Male axillary accessory breast cancer: A case report.
Bi M; Li D; Su Y; Sun P; Gao Y
Medicine (Baltimore); 2020 Mar; 99(11):e19506. PubMed ID: 32176095
[TBL] [Abstract][Full Text] [Related]
7. Male breast cancer originating in an accessory mammary gland in the axilla: a case report.
Yamamura J; Masuda N; Kodama Y; Yasojima H; Mizutani M; Kuriyama K; Mano M; Nakamori S; Sekimoto M
Case Rep Med; 2012; 2012():286210. PubMed ID: 23251170
[TBL] [Abstract][Full Text] [Related]
8. Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.
Loi S; Dafni U; Karlis D; Polydoropoulou V; Young BM; Willis S; Long B; de Azambuja E; Sotiriou C; Viale G; Rüschoff J; Piccart MJ; Dowsett M; Michiels S; Leyland-Jones B
JAMA Oncol; 2016 Aug; 2(8):1040-7. PubMed ID: 27100299
[TBL] [Abstract][Full Text] [Related]
9. A single centre experience in Turkey for comparison between core needle biopsy and surgical specimen evaluation results for HER2, SISH, estrogen receptors and progesterone receptors in breast cancer patients.
Karaman H; Senel F; Tasdemir A; Özer I; Dogan M
J Cancer Res Ther; 2022; 18(6):1789-1795. PubMed ID: 36412445
[TBL] [Abstract][Full Text] [Related]
10. Is It Contralateral Axillary Metastasis or Occult Breast Cancer?: A Confusing Case Report.
Son YG; Kim WW; Kim KH; Kim JS
Case Rep Oncol; 2015; 8(3):498-502. PubMed ID: 26668571
[TBL] [Abstract][Full Text] [Related]
11. Potential role of significant GATA3 mutation in male breast cancer responding to endocrine therapy: A case report.
Xia Y; Liu X; Li W; Zhu Y
Indian J Pathol Microbiol; 2021; 64(1):161-164. PubMed ID: 33433431
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.
Subramaniam S; Bhoo-Pathy N; Taib NA; Tan GH; See MH; Jamaris S; Ho GF; Looi LM; Yip CH
World J Surg; 2015 Oct; 39(10):2450-8. PubMed ID: 26138872
[TBL] [Abstract][Full Text] [Related]
13. A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.
Hayashi H; Kimura M; Yoshimoto N; Tsuzuki M; Tsunoda N; Fujita T; Yamashita T; Iwata H
Breast Cancer; 2009; 16(2):136-40. PubMed ID: 18548321
[TBL] [Abstract][Full Text] [Related]
14. A Case Report of Male Occult Breast Cancer First Manifesting as Axillary Lymph Node Metastasis With Part of Metastatic Mucinous Carcinoma.
He M; Liu H; Jiang Y
Medicine (Baltimore); 2015 Jun; 94(25):e1038. PubMed ID: 26107674
[TBL] [Abstract][Full Text] [Related]
15. HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab.
Li S; Wu J; Huang O; He J; Zhu L; Chen W; Li Y; Chen X; Shen K
Breast; 2020 Dec; 54():235-241. PubMed ID: 33166784
[TBL] [Abstract][Full Text] [Related]
16. Utility of Human Epidermal Growth Factor Receptor 2 (HER2) Retesting of Histologic Grade 3 Invasive Breast Carcinomas.
Gologorsky R; Cureton E; Shim V
Perm J; 2019; 23():18-088. PubMed ID: 30624197
[TBL] [Abstract][Full Text] [Related]
17. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.
Takada M; Higuchi T; Tozuka K; Takei H; Haruta M; Watanabe J; Kasai F; Inoue K; Kurosumi M; Miyazaki M; Sato-Otsubo A; Ogawa S; Kaneko Y
BMC Cancer; 2013 May; 13():241. PubMed ID: 23679233
[TBL] [Abstract][Full Text] [Related]
19. HER2-positive pure mucinous breast carcinoma: A case report and literature review.
Zhao X; Yang X; Gao R; Zhai L; Yang L; Yu K
Medicine (Baltimore); 2020 Aug; 99(33):e20996. PubMed ID: 32871976
[TBL] [Abstract][Full Text] [Related]
20. [A case of solitary adrenal metastasis from breast cancer successfully resected by laparoscopy].
Mizuyama Y; Shinto O; Tamura T; Nakagawa H; Ohno Y; Takashima T; Ishikawa T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2351-3. PubMed ID: 24394109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
